Skip to content

ATOSSA THERAPEUTICS, INC.: 10-Q filed 2013-08-14

What ATOSSA THERAPEUTICS, INC. reported in its quarterly report filed 2013-08-14 (fiscal Q2 2013): 35 published measures, 110 facts as tagged in accession 0001144204-13-045866.

This filing

Form
10-Q (quarterly report)
Filed
2013-08-14
Fiscal period
fiscal Q2 2013
Accession
0001144204-13-045866 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ATOSSA THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-06-3010,055,002USD
At 2012-12-316,826,133USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-06-308,280,832USD
At 2012-12-315,175,535USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-06-302,439,512USD
At 2012-12-311,725,197USD
At 2012-06-3087,997USD
At 2011-12-311,910,821USD
At 2009-04-290USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-2,583,699USD91
2013-01-01 to 2013-06-30-4,525,139USD181
2009-04-30 to 2013-06-30-14,257,045USD1523
2012-04-01 to 2012-06-30-1,167,948USD91
2012-01-01 to 2012-06-30-2,230,867USD182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-06-30-3,444,090USD181
2009-04-30 to 2013-06-30-11,269,705USD1523
2012-01-01 to 2012-06-30-1,816,646USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-06-304,248,275USD181
2009-04-30 to 2013-06-3014,070,601USD1523
2012-01-01 to 2012-06-30-6,178USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-06-30-89,870USD181
2009-04-30 to 2013-06-30-361,383USD1523
2012-01-01 to 2012-06-300USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-06-30-14,257,045USD
At 2012-12-31-9,731,906USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-04-01 to 2013-06-300USD91
2013-01-01 to 2013-06-300USD181
2009-04-30 to 2013-06-30250USD1523
2012-04-01 to 2012-06-300USD91
2012-01-01 to 2012-06-300USD182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-06-30205,800USD
At 2012-12-31159,967USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-06-301,011,820USD181
2009-04-30 to 2013-06-301,304,084USD1523
2012-01-01 to 2012-06-3070,662USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-2,583,347USD91
2013-01-01 to 2013-06-30-4,524,780USD181
2009-04-30 to 2013-06-30-14,223,853USD1523
2012-04-01 to 2012-06-30-1,165,812USD91
2012-01-01 to 2012-06-30-2,227,980USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-06-305,355,137USD
At 2012-12-311,989,495USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-04-01 to 2013-06-30352USD91
2013-01-01 to 2013-06-30359USD181
2009-04-30 to 2013-06-3039,530USD1523
2012-04-01 to 2012-06-302,446USD91
2012-01-01 to 2012-06-304,060USD182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-06-301,774,170USD
At 2012-12-311,650,598USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-06-30184,002USD
At 2012-12-3168,217USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2013-06-304,457,619USD
At 2012-12-314,640,224USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-06-30520,424USD
At 2012-12-31141,665USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-04-01 to 2013-06-302,687,265USD91
2013-01-01 to 2013-06-304,744,904USD181
2009-04-30 to 2013-06-3014,764,500USD1523
2012-04-01 to 2012-06-301,371,121USD91
2012-01-01 to 2012-06-302,460,998USD182

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-04-01 to 2013-06-30103,918USD91
2013-01-01 to 2013-06-30220,124USD181
2009-04-30 to 2013-06-30540,647USD1523
2012-04-01 to 2012-06-30205,309USD91
2012-01-01 to 2012-06-30233,018USD182

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2013-04-01 to 2013-06-30222,160USD91
2013-01-01 to 2013-06-30288,624USD181
2009-04-30 to 2013-06-30329,533USD1523
2012-04-01 to 2012-06-3017,788USD91
2012-01-01 to 2012-06-3020,985USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-04-01 to 2013-06-30189,955USD91
2013-01-01 to 2013-06-30410,147USD181
2009-04-30 to 2013-06-303,967,533USD1523
2012-04-01 to 2012-06-30543,081USD91
2012-01-01 to 2012-06-30961,071USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-06-3015,338,074shares
At 2012-12-3112,919,367shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-06-3022,522,539USD
At 2012-12-3114,894,522USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-06-3066,617USD
At 2012-12-3131,081USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-06-304,494,065USD
At 2012-12-314,676,671USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-06-301,558,514USD
At 2012-12-311,582,382USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2013-01-01 to 2013-06-30-4,525,139USD181
2009-04-30 to 2013-06-30-14,257,045USD1523
2012-01-01 to 2012-06-30-2,230,867USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-04-01 to 2013-06-302,177,920USD91
2013-01-01 to 2013-06-303,742,792USD181
2009-04-30 to 2013-06-309,565,126USD1523
2012-04-01 to 2012-06-30704,208USD91
2012-01-01 to 2012-06-301,305,660USD182

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-01-01 to 2013-06-3035,537USD181
2012-01-01 to 2012-06-308,647USD182

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-01-01 to 2013-06-30226,643USD181
2009-04-30 to 2013-06-30372,818USD1523
2012-01-01 to 2012-06-3017,057USD182

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2013-01-01 to 2013-06-300USD181
2009-04-30 to 2013-06-30250USD1523
2012-01-01 to 2012-06-300USD182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-06-30378,759USD181
2009-04-30 to 2013-06-30520,424USD1523
2012-01-01 to 2012-06-30177,055USD182

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-06-3020,323USD181
2009-04-30 to 2013-06-30142,233USD1523
2012-01-01 to 2012-06-3023,807USD182

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-06-30115,785USD181
2009-04-30 to 2013-06-30184,002USD1523
2012-01-01 to 2012-06-306,702USD182

Inspect the source

Entity
ATOSSA THERAPEUTICS, INC. / CIK 0001488039
Captured
2026-09-20T09:09:43.864Z
SEC response SHA-256
1a9a7394baaf8eaa5fbb9f56ff3e675865210f784ada942417e365f62ac259f6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001488039.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))